| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Wednesday - Sep 11, 2024 |
|||||||||
|
Designer Brands
DBI
|
Q2 FY24 | $0.29 | $0.53 | $771.90M | $816.14M |
NYSE |
|||
|
Oxford Industries
OXM
|
Q2 FY24 | $2.77 | $3.00 | $419.89M | $438.18M |
NYSE |
|||
|
Vera Bradley
VRA
|
Q2 FY25 | $0.13 | $0.31 | $110.82M | $109.90M |
NASDAQ |
|||
|
Perma-Pipe International Holdings
PPIH
|
- | $0.40 | - | $37.51M | - |
NASDAQ |
|||
|
Optical Cable
OCC
|
Q3 FY24 | -$0.20 | - | $16.22M | - |
NASDAQ |
|||
|
Champions Oncology
CSBR
|
Q1 FY25 | $0.11 | $0.02 | $14.06M | $13.23M |
NASDAQ |
|||
|
MIND Technology
MIND
|
- | -$0.11 | $0.02 | $10.04M | $10.75M |
NASDAQ |
|||
|
Streamline Health Solutions
STRM
|
- | -$0.75 | -$0.60 | $4.48M | $5.31M |
NASDAQ |
|||
|
Nukkleus
NUKK
|
- | -$0.11 | - | $175.21K | - |
NASDAQ |
|||
|
Alzamend Neuro
ALZN
|
- | -$11.25 | -$2.38 | - | - |
NASDAQ |
|||
